ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,848.10
-0.05%
S&P ASX All Technology
3,074.90
-0.10%
Brent Oil
81.915
-0.64%
US Dollar vs AUD
1.50445
0.30%
Bitcoin
69,881.84
-0.36%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Biofrontera AG (BFRA)

  7. Biofrontera AG (BFRA) News

BFRA

Biofrontera (BFRA)

Biofrontera AG
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BFRA
DateTimeSourceHeadlineSymbolCompany
14/03/202221:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BFRABiofrontera AG
10/03/202222:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
10/03/202208:28Edgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities Under Section 12(b) (15f-12b)NASDAQ:BFRABiofrontera AG
10/03/202206:36Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:BFRABiofrontera AG
10/03/202206:29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BFRABiofrontera AG
26/02/202208:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BFRABiofrontera AG
25/02/202208:06Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:BFRABiofrontera AG
25/02/202206:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
23/02/202202:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
15/02/202206:05GlobeNewswire Inc.Biofrontera AG decides to delist ADS from Nasdaq to reduce complexity and costsNASDAQ:BFRABiofrontera AG
02/02/202202:00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
14/01/202201:26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
15/12/202106:24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
14/12/202102:23Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
09/12/202100:44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
03/12/202102:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
02/12/202123:37Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
02/12/202122:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
30/11/202108:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BFRABiofrontera AG
30/11/202105:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
30/11/202102:24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
25/11/202102:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
20/11/202103:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
20/11/202100:45GlobeNewswire Inc.Biofrontera AG announces mediation resultsNASDAQ:BFRABiofrontera AG
18/11/202122:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
18/11/202109:00GlobeNewswire Inc.Biofrontera reports financial results for the third quarter and nine months ended September 30, 2021NASDAQ:BFRABiofrontera AG
17/11/202103:41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
17/11/202101:01GlobeNewswire Inc.Biofrontera AG announces initiation of clinical studiesNASDAQ:BFRABiofrontera AG
11/11/202101:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
10/11/202102:30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
 Showing the most relevant articles for your search:NASDAQ:BFRA

Your Recent History

TG
BIO
Biotest
BOV
BOTZ39R
Global X Funds
BIT
O8JN32
MORGAN STANLEY BV
EU
SGA4D
Euronext G Credit Agrico...
COIN
PHTRUSD
Phuture
COIN
LNBTC
LINK
DGFX
ENCWTAUSDT
Encyclopedia wTa
LSE
0H84
Dorstener Maschinenfabrik
EU
M868S
M868S
COIN
UCREUR
NYSE
CXAC.U
C5 Acquisition
LSE
WBAA
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved